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Abstract
Purpose: Only five percent of thyroid nodules are malignant. It is important to find reliable and at the same time 
non-invasive methods to identify high-risk nodules. The aim of this study was to determine the diagnostic validity 
of a morphologic feature-oriented approach of ultrasound study for the identification of malignant thyroid nodules.
Material and methods: Seventy-one thyroid nodules in 71 consecutive patients were evaluated with both ultrasonogra-
phy (US) and US-assisted fine needle aspiration biopsy (FNAB). Thyroid grey-scale and power Doppler US were 
performed, and a Windows-based software was designed to process power Doppler US (PDUS) images that were 
recorded directly by the US device. We provided a histogram graph of coloured pixels and calculated the Malignancy 
Index to identify the probability of malignancy for each thyroid nodule.
Results: Thirty-six nodules (50.7%) were determined to be malignant in FNAB. Area under the receiver operating curve 
was 0.91 (95% CI: 0.85-0.98) for PDUS-based malignancy index in differentiating malignant thyroid nodules from 
benign ones. The best cut-off point for malignancy index was determined to be 0.092, with a sensitivity of 86.1% and 
specificity of 80% in identifying malignant nodules.
Conclusions: This PDUS-driven malignancy index using a contour-finding algorithm approach could accurately and 
reliably differentiate malignant and benign thyroid nodules. As a pre-FNAB assessment, the malignancy index may 
be able to reduce the number of patients with nodular thyroid disease undergoing this invasive procedure. 
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Introduction
Thyroid nodules are the most common thyroid disease, 
and 4-7% of the adult population have palpable thyroid 
nodules [1]. Moreover, 5% of thyroid nodules are malig-
nant, and thyroid malignancies constitute about 1% of all 
cancers annually [2]. The clinical presentation differs be-
tween incidental and solitary nodules, in which cancer is 
Seyed Babak Moosavi Toomatari, Afshin Mohammadi, Nariman Sepehrvand et al.  
e518 © Pol J Radiol 2019; 84: e517-e521
a concern and should be ruled out [3]. The key point in 
the evaluation of a thyroid nodule is the discrimination 
between the benign and malignant forms of the thyroid 
nodules. 
There are many modalities that are used to assess 
the pathology of thyroid nodules, which include palpa-
tion, imaging, and biopsy. Ultrasonography is a simple, 
non-invasive, easily accessible, and cheap modality that 
is potentially useful to evaluate thyroid nodules. Several 
ultrasonographic characteristics such as taller-than-wide 
shape, marked hypoechogenicity, microcalcifications, 
irregular or microlobulate margins [4], and increased 
nodular flow visualised by Doppler ultrasound are shown 
to be associated with an increased risk of malignancy in 
nodular thyroid disease [3,5-9].
To date, ultrasound has had a limited specificity in 
the diagnosis and prognostication of thyroid malignan-
cies [3,5-8]. Some authors have suggested a change in the 
approach of using individual ultrasonographic character-
istics, suggesting new pattern recognition methods in the 
diagnosis of thyroid nodules. The purpose of this study 
was to evaluate the diagnostic accuracy of an ultra sound-
driven diagnostic index for the identification of benign or 
malignant thyroid nodules. 
Material and methods
Participants
From April 2010 to April 2013, 71 thyroid nodules from 
71 consecutive patients were evaluated in the Radiology 
Department with both ultrasonography (US) and US- 
assisted fine needle aspiration biopsy (FNAB). Each patient 
signed an informed consent form prior to participation 
in the study, and they were free to withdraw at any step. 
The study was approved by the institutional review board 
of the Urmia University of Medical Sciences, Urmia, Iran. 
A single radiologist with nine years of experience per-
formed all the studies. 
All the patients were followed up for one year, and 
they were re-evaluated at the end of 12 months by both 
ultrasound and FNAB methods. Only those patients with 
definitive diagnosis according to the FNAB report were 
included in the final analysis. Nodules were considered 
as benign if they showed no change in the one-year fol-
low-up or repeated FNAB showed no change in cytolo-
gical findings. The exclusion criteria (according to cyto-
logical report) were: indeterminate cytological changes, 
suspicious for malignancy or inadequate cytological 
findings.
Ultrasonography
Thyroid grey-scale and power Doppler US were per-
formed using a Medison Accuvix V20 machine (Medi-
son, South Korea) with a 7-12-MHz broadband width 
transducer. The colour map of this device consists of 128 
colours, each representing a different velocity (Figure 1).
Power Doppler ultrasonography (PDUS) was per-
formed for all of the subjects before undergoing FNAB. 
We assessed the arteriole blood flow within the thyroid 
nodules. Power Doppler sonographies were used (pulse 
repetition frequency at minimum – 0.4-0.6 kHz) to obtain 
even the low blood flows. Specific settings included Dop-
pler depth of 3 cm; overall gain equal to 60 dB; time gain 
compensation vertical and centred; power Doppler gain 
of 15-20 dB; and wall filter set at minimum. 
Fine needle aspiration biopsy
An experienced radiologist performed ultrasound-guided 
FNAB in all patients with extended neck and supine po-
sition. In the first stage, after preparing a sterile field on 
the neck, the lesion was localised. Under ultrasound ob-
servation, until it was visible as a bright spot on the mon-
itor, a 23-gauge needle attached to a 20-ml syringe was 
inserted perpendicularly to the neck until the needle was 
introduced to the target thyroid nodule. This procedure 
was performed without local anaesthesia. On real-time 
monitoring, aspiration and suction were performed with 
to-and-from movements, and suction was released before 
withdrawing the needle. At least four suction attempts 
were made. Subsequently, needle aspiration staining with 
Papanicolaou and Giemsa was performed on glass slides. 
The results of the thyroid cytopathology, which were 
assessed by an experienced thyroid pathologist, were re-
ported at the first step as diagnostic (satisfactory: at least 
six groups of benign follicles, each group composed of at 
least 10 cells in aspirated samples) or non-diagnostic (or 
unsatisfactory). 
Cytopathology was reported as benign (colloid nod-
ules, adenomatous nodules, lymphocytic thyroiditis, and 
other), indeterminate (follicular or Hurthle cell neo-
Figure 1. Ultrasonogram shows power Doppler sonography image of a thy-
roid nodule
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plasm), suspicious for malignancy, or malignant (papil-
lary, follicular, medullary, and undifferentiated thyroid 
carcinoma), according to the Bethesda System for report-
ing thyroid cytopathology. Cytologic results were consid-
ered malignant when the specimen showed abundant cells 
with cytological features of cancer. Only those patients 
with a definitive pathological diagnosis such as benign or 
malignant disease were included in the study. 
Malignancy Index
We designed a Windows-based software to process pow-
er Doppler US images that were recorded directly by the 
US device in Bitmap [BMP] format. In order to process 
the images, they were transferred from the US device to 
a desktop computer. All images had the same character-
istics: width, 1024 pixels; height, 768 pixels; vertical and 
horizontal resolution, 72 dpi; and bit depth, 24. The pro-
cessing of images in this software consists of the four fol-
lowing steps (Figure 2):
Step one: Loading the power Doppler US bitmap im-
age and extracting the border of thyroid nodule by man-
ually drawing a region of interest; Step two: measuring 
total pixels, number of coloured pixels, and number of 
pixels for each colour in the thyroid nodule; Step three: 
providing the histogram graph of the coloured pixels (Fig-
ure 3) and calculating the mean and standard deviation; 
Step four: calculating the Malignancy Index to identify 
the probability of malignancy for each thyroid nodule as 
defined below:
The flow speed in power Doppler images is shown as 
colour dots (pixels). The colour spectrum consisted of 128 
different colours, and each speed was designated as one 
colour. We then drew a histogram for each nodule, with 
the horizontal axis showing the speed of the flow in the 
nodule as showed in the power Doppler image, and the 
vertical axis showing the number of coloured dots or pix-
els corresponding to that speed. By having the histogram 
for each nodule, we determined the mean and standard 
deviation of the flow speed and calculated the malignancy 
index (Zahra Index) based on these numbers and other 
parameters that we extracted from the power Doppler 
images. 
(Total pixels) 
Zahra Index =
Standard deviation
Average
× Coloured pixels
× 100
Statistical analysis
Receiver operating characteristic (ROC) plots were 
used to illustrate the sensitivity versus specificity for all 
possible cut-off values. The area under the curve (AUC) 
was calculated as a measure of test accuracy to distinguish 
malignant tumours from benign nodules. All data analy-
ses were performed using SPSS (Version 21.0; IBM SPSS 
Corporation, Chicago, IL).
Results
Thirty-six nodules (50.7%) were determined to be malig-
nant via FNAB, and 35 nodules (49.3%) were diagnosed 
to be benign (Table 1). ROC curve analysis found an AUC 
of 0.91 (95% CI: 0.85-0.98) for PDUS-based malignancy 
index in distinguishing malignant tumours from the be-
nign ones. All possible cut-off values were assessed in the 
ROC curve analysis (Figure 4). The best trade-off point 
between sensitivity and specificity was a malignancy index 
of 0.092, showing a sensitivity of 86.1% (95% CI: 70.5-
95.3%) and specificity of 80.0% (95% CI: 63.0-91.5%). 
The positive predictive value, negative predictive value, 
Loading the power Doppler US bitmap image
Extracting the border of thyroid nodule 
Analyzing image pixels 
Providing  
the histogram graph 
of colored pixels
Calculating  
the mean and 
standard deviation 
Calculating  
the Malignancy Index
Measuring number 
of colored pixels 
Measuring 
total pixels 
Measuring number 
of pixels 
for each color value 
Figure 2. Simple algorithm of analysing power Doppler images
Figure 3. Histogram graph of pixel scattering for power Doppler data of 
a thyroid nodule
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and diagnostic accuracy were 81.5% (95% CI: 69.2-89.7%), 
84.8% (95% CI: 71.0-92.8%), and 83.1% (95% CI: 72.3-
90.9%), respectively. 
Discussion
Because of the high prevalence of thyroid nodules, es-
pecially in iodine-deficient areas, it is essential to find 
accurate and cost-effective ways of identifying high-risk 
thyroid nodules according to ultrasound features. By us-
ing advanced ultrasonographic devices, ultrasonography 
is now highly sensitive in determining the size and the 
number of the thyroid nodules. However, it still cannot re-
liably distinguish a malignant nodule from a benign one. 
Ultrasonographic features such as hypoechogenici-
ty, microcalcifications, intranodular vascularity, and the 
lack of halo margins are shown to be associated with the 
presence of malignancy in thyroid nodules [10-13]. How-
ever, these ultrasonographic features had relatively low 
sensitivity in identifying patients that indicate an invasive 
procedure such as FNAB [14-17].
Studies have shown that the nodules with a predomi-
nantly peri-nodular vascular pattern have a lower risk of 
malignancy than nodules with an exclusively central vas-
cular pattern. Moon et al. [17] demonstrated that among 
ultrasonographic features of thyroid nodules, intra-nodu-
lar vascularity can predict the risk of malignancy more ac-
curately than other ultrasonographic criteria. Ultrasound 
criteria, consisting of “taller than wide” shape, spiculated 
margin, marked hypoechogenicity, microcalcification, and 
macrocalcification, were reported to have a diagnostic 
accuracy of 77% in identifying malignant nodules when 
at least one US feature of malignancy was present [18]. 
The low accuracy observed in that study may be attributed 
to the absence of intra-nodular vascularity in the diagnos-
tic criteria. 
The PDUS-driven index of vascularity, a.k.a. malig-
nancy index, had high performance in this study in dif-
ferentiating malignant and benign thyroid nodules. Using 
a cut-off point of 0.092, the malignancy index had a di-
agnostic accuracy of 83%, and both the sensitivity and 
specificity were higher than the rates reported before in 
the literature for ultrasonographic parameters [18]. 
FNAB has been accepted as the gold standard test in 
the diagnosis of nodular thyroid disease, and FNAB under 
ultrasound guidance has a sensitivity rate of up to 100% in 
identifying malignant nodules [19]. Despite the high ac-
curacy, the procedure is invasive and painful. PDUS-driv-
en malignancy index can identify those with a higher risk 
of malignancy in thyroid nodules and can minimise the 
number of patients who require further testing with in-
vasive FNAB. 
There are a few limitations to mention here. A two- 
dimensional PDUS approach was applied in this study 
because we wanted the diagnostic test to be feasible in al-
most every setting. Several studies have shown the advan-
tages of using a 3D system because it visualises the whole 
lesion instead of applying limited transverse and longi-
tudinal planes with two-dimensional ultrasound [20,21]. 
Testing this index in future in 3-D PDUS is recommend-
ed. Further prospective studies with larger sample sizes 
are warranted for external validation of this index.
Conclusions
The PDUS-driven malignancy index using contour-find-
ing algorithm software was accurate and reliable in dif-
ferentiating malignant and benign thyroid nodules. This 
method may be reliably applied as a pre-FNAB risk strat-
ification tool to minimise the number of invasive proce-
dures in nodular thyroid disease.
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Table 1. Diagnostic performance of PDUS-driven malignancy index 
Pathology
Malignant Benign Total
Malignancy 
index
Malignant TP 31 FP 7 38
Benign FN 5 TN 28 33
Total 36 35 71
FN – false negative, FP – false positive, TN – true negative, TP – true positive, PDUS – power 
Doppler ultrasonography
Figure 4. Receiver operating characteristic curve for malignancy index in 
identifying malignant thyroid nodules
Se
ns
iti
vit
y
1 – Specificity
1.0
0.8
0.6
0.4
0.2
0
0 0.2 0.4 0.6 0.8 1.0
 Thyroid vascularity for identifying malignant thyroid nodules
e521© Pol J Radiol 2019; 84: e517-e521
References
1. Singer PA, Cooper DS, Daniels GH, et al. Treatment guidelines for 
patients with thyroid nodules and well-differentiated thyroid cancer. 
American Thyroid Association. Arch Intern Med 1996; 156: 2165-2172.
2. Wong CK, Wheeler MH. Thyroid nodules: rational management. 
World J Surg 2000; 24: 934-941.
3. Hegedus L. Thyroid ultrasound. Endocrinol Metab Clin North Am 
2001; 30: 339-360, viii-ix.
4. Park AY, Son EJ, Han K,et al. Shear wave elastography of thyroid 
nodules for the prediction of malignancy in a large scale study. Eur 
J Radiol 2015; 84: 407-412.
5. Hegedus L, Bonnema SJ, Bennedbaek FN. Management of simple 
nodular goiter: current status and future perspectives. Endocr Rev 
2003; 24: 102-132.
6. Hong YJ, Son EJ, Kim EK, et al. Positive predictive values of so-
nographic features of solid thyroid nodule. Clin Imaging 2010; 34: 
127-133.
7. Mazzaglia PJ. Surgeon-performed ultrasound in patients referred for 
thyroid disease improves patient care by minimizing performance of 
unnecessary procedures and optimizing surgical treatment. World 
J Surg 2010; 34: 1164-1170.
8. Mendelson AA, Tamilia M, Rivera J, et al. Predictors of malignancy 
in preoperative nondiagnostic biopsies of the thyroid. J Otolaryngol 
Head Neck Surg 2009; 38: 395-400.
9. Park M, Shin JH, Han BK, et al. Sonography of thyroid nodules 
with peripheral calcifications. J Clin Ultrasound 2009; 37: 324-328.
10. Cappelli C, Castellano M, Pirola I, et al. The predictive value of 
ultrasound findings in the management of thyroid nodules. QJM 
2007; 100: 29-35.
11. Horvath E, Majlis S, Rossi R, et al. An ultrasonogram reporting sys-
tem for thyroid nodules stratifying cancer risk for clinical manage-
ment. J Clin Endocrinol Metab 2009; 94: 1748-1751.
12. Salmaslioğlu A, Erbil Y, Dural C, et al. Predictive value of sono-
graphic features in preoperative evaluation of malignant thyroid 
nodules in a multinodular goiter. World J Surg 2008; 32: 1948-1954.
13. Mohammadi A, Hajizadeh T. Evaluation of diagnostic efficacy of 
ultrasound scoring system to select thyroid nodules requiring fine 
needle aspiration biopsy. Int J Clin Exp Med 2013; 6: 641-648.
14. González-González A, Mate Valdezate A, Parra Arroyo A, et al. Dia-
gnostic efficiency of sonographic findings of thyroid nodules in the 
detection of malignancy. Endocrinol Nutr 2010; 57: 240-244.
15. Leenhardt L, Tramalloni J, Aurengo H, et al. Echography of thyroid 
nodules. The echography specialist facing the clinician’s require-
ments. Presse Med 1994; 23: 1389-1392.
16. Li QS, Chen S, Xiong H, et al. Papillary thyroid carcinoma on 
sonography. Clin Imaging 2010; 34: 121-126.
17. Moon HJ, Kwak JY, Kim MJ, et al. Can vascularity at power Doppler 
US help predict thyroid malignancy? Radiology 2010; 255: 260-269.
18. Moon WJ, Jung SL, Lee JH, et al. Benign and malignant thyroid 
nodules: US differentiation – multicenter retrospective study. Radio-
logy 2008; 247: 762-770.
19. Abu-Salem OT. FNAB thyroid gland: comparison study between 
pre- and post-operative histological diagnosis. Arch Inst Pasteur 
Tunis 2003; 80: 57-60.
20. Li WB, Zhang B, Jiang YX, et al. Value of quantitative three-dimen-
sional doppler ultrasound in the differentiation of benign and ma-
lignant thyroid nodules. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 
2015; 37: 300-304.
21. Slapa RZ, Jakubowski WS, Slowinska-Srzednicka J, et al. Advantages 
and disadvantages of 3D ultrasound of thyroid nodules including 
thin slice volume rendering. Thyroid Res 2011; 4: 1.
